Anti-herpes virus activities of Achyranthes aspera: An Indian ethnomedicine, and its triterpene acid

Microbiological Research

Volumn 168, Issue 4, 2013, Pages 238-244

  Mukherjee, Hemanta ^a   Ojha, Durbadal ^a   Bag, Paromita ^a   Chandel, Himanshu Singh ^b   Bhattacharyya, Souvik ^d   Chatterjee, Tapan K ^d   Mukherjee, Pulok K ^d   Chakraborti, Sekhar ^a,c   Chattopadhyay, Debprasad ^a  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^b NATIONAL CENTRE FOR CELL SCIENCE   (India)

^c NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

^d JADAVPUR UNIVERSITY   (India)

Author keywords

Achyranthes aspera; Antiviral activity; Ethnomedicine; Herpes simplex virus; Oleanolic acid

Indexed keywords

ACHYRANTHES ASPERA; ANTIVIRAL ACTIVITIES; ETHNOMEDICINE; HERPES SIMPLEX VIRUS; OLEANOLIC ACIDS;

DRUG PRODUCTS; POLYMERASE CHAIN REACTION;

VIRUSES;

ANTIVIRUS AGENT; PLANT EXTRACT; TRITERPENE;

ANTIMICROBIAL ACTIVITY; BIOCHEMICAL COMPOSITION; DICOTYLEDON; DISEASE TREATMENT; DRUG; ETHNOBOTANY; PHYTOCHEMISTRY; PLANT EXTRACT; TERPENE; VIRAL DISEASE; VIRUS;

ACHYRANTHES; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CELL LINE; CERCOPITHECUS; CHEMISTRY; DRUG EFFECT; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; IMMUNOLOGY; INDIA; MACROPHAGE; MOUSE; TRADITIONAL MEDICINE; VERO CELL; VIROLOGY;

ACHYRANTHES; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CERCOPITHECUS AETHIOPS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; INDIA; MACROPHAGES; MEDICINE, TRADITIONAL; MICE; MICE, INBRED BALB C; PLANT EXTRACTS; TRITERPENES; VERO CELLS;

INDIA;

ACHYRANTHES ASPERA; HERPESVIRIDAE; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; SIMPLEXVIRUS;

EID: 84875380776     PISSN: 09445013     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micres.2012.11.002     Document Type: Article

References (35)

1. Arunachalam G., Bag P., Chattopadhyay D. Phytochemical and phytotherapeutic evaluation of Mallotus peltatus (Geist.) Muell. Arg. var acuminatus and Alstonia macrophylla wall ex A. DC: two ethno medicine of Andaman Islands, India. J Pharmacog Phytother 2009, 1(1):1-20.
2. Aziz A., Rahman M., Mondal A.K., Muslim T., Rahman A., Quader A. 3-Acetoxy-6-benzoyloxyapagamide from Achyranthes aspera. Pharm J 2005, 4:1820-1824.
3. Bag P., Chattopadhyay D., Mukherjee H., Ojha D., Mandal N., Sarkar M.C., et al. Anti-herpes virus activities of bioactive fraction and isolated pure constituent of Mallotus peltatus: an ethnomedicine from Andaman Islands. Virol J 2012, 9:98.
4. Barua C.C., Talukdar A., Begum S.A., Lahon L.C., Sarma D.K., Pathak D.C., et al. Antinociceptive activity of methanol extract of leaves of Achyranthes aspera Linn. (Amaranthaceae) in animal models of nociception. Indian J Exp Biol 2010, 48:817-821.
5. Bernstein D.I., Stanberry L.R. Herpes simplex virus vaccines. Vaccine 1999, 17(13-14):1681-1689.
6. Carr J.A., Rogerson J., Mulqueen M.J., Roberts N.A., Booth R.F. Interleukin-12 exhibits potent antiviral activity in experimental herpesvirus infections. J Virol 1997, 71(10):7799-7803.
7. Chakraborty A., Brantner A., Mukuinaka T., Nobukuni Y., Kuchido M., Konoshima T., et al. Cancer chemo-preventive activity of Achyranthes aspera leaves on Epstein-Barr virus activation and two stage mouse skin carcinogenesis. Cancer Lett 2002, 177:1-5.
8. Chattopadhyay D., Chawla Sarkar M., Chatterjee T., Dey R., Bag P., Chakrabarty S., et al. Recent advancements for the evaluation of antiviral activities of natural products. New Biotechnol 2009, 25(5):347-368.
9. Chiang L.C., Chiang W., Liu M.C., Lin C.C. In vitro antiviral activities of Caesapinia pulcherrima and its related flavonoids. J Antimicrob Chemother 2003, 52:194-198.
10. Clercq E.D. Antiviral drugs in current clinical use. J Clin Virol 2004, 30(2):115-133.
11. Ellermann-Eriksen S. Autocrine secretion of interferon-a/b and tumour necrosis factor-a synergistically activates mouse macrophages after infection with herpes simplex virus type 2. J Gen Virol 1993, 74:2191-2199.
12. Goyal B.R., Goyal R.K., Mehta A.A. Phyto-pharmacology of Achyranthes aspera: a review. Pharmacog Rev 2007, 1(1):143-150.
13. Jang S.M., Yee S.T., Choi J., Choi M.S., Do G.M., Jeon S.M., et al. Ursolic acid enhances the cellular immune system and pancreatic β-cell function in streptozotocin-induced diabetic mice fed a high-fat diet. Int J Immunopharmacol 2009, 9:113-119.
14. Kashiwada Y., Nagao T., Hashimoto A., Ikeshiro Y., Okabe H., Cosentino L.M., et al. Anti-AIDS agents 38, anti-HIV activity of 3-O-acyl ursolic acid derivatives. J Nat Prod 2000, 63:1619-1622.
15. Kleymann G. New antiviral drugs that target herpesvirus helicase primase enzymes. Herpes 2003, 10(2):46-52.
16. Kontogianni V.G., Exarchou V., Troganis A., Gerothanassis L.P. Rapid and novel discrimination and quantification of oleanolic and ursolic acids in complex plant extracts using two-dimensional nuclear magnetic resonance spectroscopy - comparison with HPLC methods. Anal Chim Acta 2009, 635(2):188-195.
17. Li J., Wei-Jian Guo W.J., Yang Q.Y. Effects of ursolic acid and OA on human colon carcinoma cell line HCT15. World J Gastroenterol 2002, 8(3):493-495.
18. Lin L.-T., Chen T.-Y., Chung C.-Y., Noyce R.S., Grindley T.B., McCormick C., et al. Hydrolyzable tannins (chebulagic acid and punicalagin) target viral glycoprotein-glycosaminoglycan interactions to inhibit herpes simplex virus 1 entry and cell-to-cell spread. J Virol 2011, 85(9):4386-4398.
19. Liu J. Pharmacology of OA and ursolic acid. J Ethnopharmacol 1995, 49:57-68.
20. Madan R.P., Mesquita P.M.M., Cheshenko N., Jing B., Shende V., Guzman E., et al. Molecular umbrellas: a novel class of candidate topical microbicides to prevent human immunodeficiency virus and herpes simplex virus infections. J Virol 2007, 81:7636-7646.
21. Miller R.L., Gerster J.F., Owens M.L., Slade H.B., Tomai M.A. Imiquimod applied topically: a novel immune response modifier and new class of drug. Int J Immunopharmacol 1999, 21:1-14.
22. Miserocchi E., Modorati G., Galli L., Rama P. Efficacy of valacyclovir vs acyclovir for the prevention of recurrent herpes simplex virus eye disease: a pilot study. Am J Ophthalmol 2007, 144(4):547-551.
23. Naoumov N.V., Rossol S. Studies of interleukin-12 in chronic hepatitis B virus infection. J Viral Hepat 1997, 4(2):87-91.
24. Nehete J.Y., Deshmukh V.N., Shewale V.V., Narkhede M.R., Aurangabadkar V.M. Quantitation of OA in achyranthes aspera: l. Roots and leaves extracts by high-performance thin-layer chromatography. Int J Pharm Res Dev 2009, 7:1-6.
25. Orange J.S., Biron C.A. Characterization of early IL-12, IFN-a/b, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J Immunol 1996, 156:4746-4756.
26. Paludan S.R. Requirements for the induction of interleukin-6 by herpes simplex virus-infected leukocytes. J Virol 2001, 75(17):8008-8015.
27. Roizman B., Knipe D.M., Whitley R.J. Herpes simplex viruses. Fields virology 2007, vol. 2:2501-2601. Lippincott, Williams & Wilkins, Philadelphia, PA. 5th ed.
28. Sawyer M.H., Webb D.E., Balow J.E., Straus S.E. Acyclovir-induced renal failure, clinical course and histology. Am J Med 1988, 84(6):1067-1071.
29. Sebastian M.K., Bhandari M.M. Medico ethnobotany of Mount Abu, Rajasthan, India. J Ethnopharmacol 1984, 12:223-230.
30. Srivastava S., Singh P., Mishra G., Jha K.K., Khosa R.L. Achyranthes aspera - an important medicinal plant: a review. J Nat Prod Plant Resour 2011, 1(1):1-14.
31. Stanberry L.R. Clinical trials of prophylactic and therapeutic herpes simplex virus vaccines. Herpes 2004, 11(A):161-169.
32. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003, 3:133-146.
33. Valsaraj R., Pushpangadan P., Smitt U.W., Andersen A., Nyman U. Antimicrobial screening of selected medicinal plants from India. J Ethnopharmacol 1997, 58:75-83.
34. Vogel J.U., Weber B., Doerr H.W. Typing and strain differentiation of clinical herpes simplex virus type 1 and 2 isolates by polymerase chain reaction and subsequent restriction fragment length polymorphism analysis. Zentralbl Babkteriol 1994, 281(4):502-512.
35. Whitley R.J., Roizman B. Herpes simplex virus infections. Lancet 2001, 357(9267):1513-1518.